These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7210734)

  • 1. [Experiences with oral N-acetyl-cysteine treatment in children suffering from cystic fibrosis (author's transl)].
    Dietzsch HJ; Berger G; Gottschalk B; Leupold W; Mittenzwey KW; Rupprecht E; Wunderlich P
    Z Erkr Atmungsorgane; 1980; 155(1):109-13. PubMed ID: 7210734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis: comparison of two mucolytic drugs for inhalation treatment (acetylcysteine and arginine hydrochloride).
    Dietzsch HJ; Gottschalk B; Heyne K; Leupoid W; Wunderlich P
    Pediatrics; 1975 Jan; 55(1):96-100. PubMed ID: 1110869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of N-acetyl-cysteine (Mucosolvin) on the transmural potential difference of the mucosa in children.
    Ballke EH; Wiersbitzky S; Mahner B; König A
    Padiatr Grenzgeb; 1992; 31(2):97-101. PubMed ID: 1305285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral acetylcysteine in cystic fibrosis. A co-operative study.
    Götz M; Kraemer R; Kerrebijn KF; Popow C
    Eur J Respir Dis Suppl; 1980; 111():122-6. PubMed ID: 7011832
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oral mucosolvin therapy of pulmonary symptoms of mucoviscidosis].
    Boehm G; Theile H
    Kinderarztl Prax; 1979 Dec; 47(12):633-40. PubMed ID: 393896
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of the mucolytic agent, mucosolvin, in multiple modality treatment of cystic fibrosis in children].
    Zoirova RR
    Pediatriia; 1983 Apr; (4):36-7. PubMed ID: 6877915
    [No Abstract]   [Full Text] [Related]  

  • 7. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.
    Sims EJ; Clark A; McCormick J; Mehta G; Connett G; Mehta A;
    Pediatrics; 2007 Jan; 119(1):19-28. PubMed ID: 17200267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
    Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF
    Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral ciprofloxacin therapy in juvenile patients with cystic fibrosis--results of a prospective pilot study].
    Sollich V; Klöditz E; Schuster R; Handrick W; Brömme S; Rumler W; Patsch R; Kharari H; Spencker FB
    Kinderarztl Prax; 1993 Aug; 61(6):211-4. PubMed ID: 8411847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis.
    Jones KM; Liao E; Hohneker K; Turpin S; Henry MM; Selinger K; Hsyu PH; Boucher RC; Knowles MR; Dukes GE
    Pharmacotherapy; 1997; 17(2):263-70. PubMed ID: 9085317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNase in stable cystic fibrosis infants: a pilot study.
    Berge MT; Wiel Ev; Tiddens HA; Merkus PJ; Hop WC; de Jongste JC
    J Cyst Fibros; 2003 Dec; 2(4):183-8. PubMed ID: 15463871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function.
    Padman R; McColley SA; Miller DP; Konstan MW; Morgan WJ; Schechter MS; Ren CL; Wagener JS;
    Pediatrics; 2007 Mar; 119(3):e531-7. PubMed ID: 17332172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of high-dose ibuprofen in a pediatric cystic fibrosis center.
    Fennell PB; Quante J; Wilson K; Boyle M; Strunk R; Ferkol T
    J Cyst Fibros; 2007 Apr; 6(2):153-8. PubMed ID: 16844429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cystic fibrosis: special value of treatment at a center].
    Mannes GP; Heijerman HG
    Ned Tijdschr Geneeskd; 1997 Oct; 141(42):2001-4. PubMed ID: 9550750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of effect of intravenous antibiotics on spirometry and sputum cytokines in children with cystic fibrosis.
    Cunningham S; McColm JR; Mallinson A; Boyd I; Marshall TG
    Pediatr Pulmonol; 2003 Jul; 36(1):43-8. PubMed ID: 12772222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany).
    Siret D; Bretaudeau G; Branger B; Dabadie A; Dagorne M; David V; de Braekeleer M; Moisan-Petit V; Picherot G; Rault G; Storni V; Roussey M
    Pediatr Pulmonol; 2003 May; 35(5):342-9. PubMed ID: 12687590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study.
    van Ewijk BE; van der Zalm MM; Wolfs TF; Fleer A; Kimpen JL; Wilbrink B; van der Ent CK
    Pediatrics; 2008 Dec; 122(6):1171-6. PubMed ID: 19047230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis.
    Schnabel D; Grasemann C; Staab D; Wollmann H; Ratjen F;
    Pediatrics; 2007 Jun; 119(6):e1230-8. PubMed ID: 17545356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study.
    Westerman EM; Le Brun PP; Touw DJ; Frijlink HW; Heijerman HG
    J Cyst Fibros; 2004 Mar; 3(1):23-8. PubMed ID: 15463883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis.
    Esmond G; Butler M; McCormack AM
    J Clin Nurs; 2006 Jan; 15(1):52-60. PubMed ID: 16390524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.